Juliette Martin, Ph.D.

After completing her Ph.D. in organic synthesis at the University of Caen (France), Juliette conducted an industrial postdoctoral fellowship in asymmetric chemocatalysis at Zeneca Life Science Molecules in the UK. In 1999, she joined Avecia (UK) as R&D Team Manager focusing on New Technology Platforms involving chemo- and biocatalysis. In 2006, she joined SEQENS once the new joint venture was created with the biotech company Protéus (France). In 2009, she became R&D Manager focusing on some key technologies in process development. She then became Head of Biocatalysis for Pharma Synthesis. In 2012, she was appointed General Manager of Protéus.